Literature DB >> 4042415

Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

P Woo, P J Lachmann, R A Harrison, N Amos, C Cooper, F S Rosen.   

Abstract

Simultaneous turnover of normal and dysfunctional C1-inhibitor (C1-INH) was carried out in 10 normal subjects and 13 patients with rheumatoid arthritis as a measure of the in vivo activation of C1 and the contact activatable enzymes. In the first series of experiments, dysfunctional protein We was used in simultaneous turnover studies in five normal subjects and nine patients. The fractional catabolic rate of the dysfunctional C1-INH, We, (FCR(d)) was unchanged in both groups but the fractional catabolic rate of the normal C1-INH (FCR(n)) was faster in the patients compared to the controls, in particular patients with vasculitis. The enzyme-dependent catabolism defined as FCR(n-d) X concentration of C1-INH X plasma volume, was raised in the patient group, and correlated with disease activity score (r = 0.83, P less than 0.05). Neither FCR(n) nor FCR(d) was dependent on C1-INH concentration. The latter was higher in the patients (206 mg/l compared with 155 mg/l) indicating a very high synthetic rate in the patients (280.81 micrograms/kg/h compared with 179.77 micrograms/kg). In the second series of turnovers in six patients and five normal subjects, another dysfunctional C1-INH, at, was used. The FCR of C1-INH was slower than C1-INH (We) (1.88%/h compared with 2.7%/h). Enzyme-dependent catabolism of C1-INH in these patients were raised and also correlated with disease activity score (r = 0.82, P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042415      PMCID: PMC1577237     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.

Authors:  T J PEKIN; N J ZVAIFLER
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

3.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

4.  Metabolism of the third component of complement (C3) in patients with rheumatoid arthritis.

Authors:  A Weinstein; K Peters; D Brown; R Bluestone
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb

5.  ELISA assays for IgM and IgG rheumatoid factors.

Authors:  A Faith; O Pontesilli; A Unger; G S Panayi; P Johns
Journal:  J Immunol Methods       Date:  1982-12-17       Impact factor: 2.303

6.  Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

Authors:  M Quastel; R Harrison; M Cicardi; C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Human C1 inhibitor: improved isolation and preliminary structural characterization.

Authors:  R A Harrison
Journal:  Biochemistry       Date:  1983-10-11       Impact factor: 3.162

10.  Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factor.

Authors:  R A Kaplan; J G Curd; D H Deheer; D A Carson; M K Pangburn; H J Müller-Eberhard; J H Vaughan
Journal:  Arthritis Rheum       Date:  1980-08
View more
  6 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  C-1 inhibitor activity levels in active rheumatoid and psoriatic arthritis.

Authors:  M Maqaro; L Altomonte; A Zoli; L Mirone; M Berchicci; G Corvino
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 3.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

4.  A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.

Authors:  A de Agostini; P A Patston; V Marottoli; S Carrel; P C Harpel; M Schapira
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.

Authors:  J J Abbink; A M Kamp; J H Nuijens; A J Erenberg; A J Swaak; C E Hack
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

6.  The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.

Authors:  Yong Min Chae; Jong Kwon Park
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.